Literature DB >> 8408555

Preventing false positives: quantitative evaluation of three protocols for inactivation of polymerase chain reaction amplification products.

P N Rys1, D H Persing.   

Abstract

False-positive results because of carryover contamination by previously amplified nucleic acids are currently the greatest impediment to routine implementation of nucleic acid amplification protocols. We evaluated three methods for inactivation of a 156-bp Borrelia burgdorferi polymerase chain reaction (PCR) product: (i) post-PCR cross-linking with isopsoralen (IP), (ii) pre-PCR treatment of a dU-containing PCR product with uracil N-glycosylase (UNG), and (iii) post-PCR alkaline hydrolysis (primer hydrolysis) of PCR products synthesized by using primers containing 3' ribose residues. The sensitivities of the PCR performed under the conditions of each protocol were comparable. Inactivation of amplified DNA was highly efficient for all three protocols; the IP and UNG protocols eliminated at least to 3 x 10(9) copies of the product. The primer hydrolysis protocol varied in efficiency depending on the number and position of the 3' ribose residues, but inactivation ranged from 10(4) to 10(9) copies. We conclude that with some modifications, all three systems are effective for eliminating amplified DNA products. Routine implementation of at least one method should help to avoid false-positive results because of carryover contamination.

Entities:  

Mesh:

Year:  1993        PMID: 8408555      PMCID: PMC265760          DOI: 10.1128/jcm.31.9.2356-2360.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  More light on PCR contamination.

Authors:  G Sarkar; S Sommer
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

Review 2.  Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry.

Authors:  G D Cimino; H B Gamper; S T Isaacs; J E Hearst
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Shedding light on PCR contamination.

Authors:  G Sarkar; S S Sommer
Journal:  Nature       Date:  1990-01-04       Impact factor: 49.962

4.  Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication.

Authors:  J C Guatelli; K M Whitfield; D Y Kwoh; K J Barringer; D D Richman; T R Gingeras
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  Avoidance of PCR false positives [corrected].

Authors:  P A Kitchin; Z Szotyori; C Fromholc; N Almond
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

6.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

7.  Replicatable RNA reporters.

Authors:  F R Kramer; P M Lizardi
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

8.  Reaction of sodium hypochlorite with nucleic acids and their constituents.

Authors:  H Hayatsu; S Pan; T Ukita
Journal:  Chem Pharm Bull (Tokyo)       Date:  1971-10       Impact factor: 1.645

9.  Detection of Borrelia burgdorferi DNA in museum specimens of Ixodes dammini ticks.

Authors:  D H Persing; S R Telford; P N Rys; D E Dodge; T J White; S E Malawista; A Spielman
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

10.  Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions.

Authors:  M C Longo; M S Berninger; J L Hartley
Journal:  Gene       Date:  1990-09-01       Impact factor: 3.688

View more
  40 in total

Review 1.  Molecular diagnosis of herpes simplex virus infections in the central nervous system.

Authors:  Y W Tang; P S Mitchell; M J Espy; T F Smith; D H Persing
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Clinically applicable multiplex PCR for four middle ear pathogens.

Authors:  P H Hendolin; L Paulin; J Ylikoski
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 3.  False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy.

Authors:  A Borst; A T A Box; A C Fluit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-10       Impact factor: 3.267

4.  Use of chimeric DNA-RNA primers in quantitative PCR for detection of Ehrlichia canis and Babesia canis.

Authors:  Ofer Peleg; Gad Baneth; Osnat Eyal; Jacob Inbar; Shimon Harrus
Journal:  Appl Environ Microbiol       Date:  2009-07-24       Impact factor: 4.792

5.  Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens.

Authors:  U Reischl; N Lehn; H Wolf; L Naumann
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Evaluation of AMPLILINK software for the COBAS AMPLICOR system.

Authors:  H H Kessler; D Jungkind; E Stelzl; S Direnzo; S K Vellimedu; K Pierer; B Santner; E Marth
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

7.  Optimal activation of isopsoralen to prevent amplicon carryover.

Authors:  G A Fahle; V J Gill; S H Fischer
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

8.  Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR.

Authors:  A C Whelen; T A Felmlee; J M Hunt; D L Williams; G D Roberts; L Stockman; D H Persing
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction.

Authors:  B E Ley; C J Linton; D M Bennett; H Jalal; A B Foot; M R Millar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

10.  Dependence of polymerase chain reaction product inactivation protocols on amplicon length and sequence composition.

Authors:  M J Espy; T F Smith; D H Persing
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.